Joel Iff

Company: Sarepta Therapeutics

Job title: Executive Director - Global Access, Value & Evidence

Seminars:

Tailoring Value Propositions to Overcome Access Barriers in Cell & Gene Therapies 1:40 pm

Showcase how some Gene Therapies (GTs) are facing significant barriers to successful price and reimbursement Understand key payer value barriers for GTs and how these vary by type of gene therapy, namely: Durability of effect Unmet need Cost offsets Discuss evidence generation strategies to mitigate each of these payer barriers and optimize payer value propositions…Read more

day: Conference Day Two